Latest News

Yale researchers have created a new technology to maximize the effectiveness and reach of mRNA vaccines. 

The fall season brings a new COVID-19 vaccine and CDC officials are encouraging everyone over 6 months old to get vaccinated —including pregnant women. In this 3 Essential Questions feature, Dr. Linda Niccolai discusses the findings of a new CDC study that emphasizes the importance of pregnant women getting vaccinated to reduce the risk of their newborns being hospitalized with COVID-19.

The Yale School of Public health joins the Common Health Coalition with over 50 health organizations dedicated to strengthening public health and health care collaborations.

A multidisciplinary team of Yale scientists has received a $4-million federal grant to study the effectiveness of a new vaccine and monoclonal antibody shot designed to prevent respiratory syncytial virus (RSV) in infants.

The Connecticut Emerging Infections Program (EIP) at the Yale School of Public Health has received a five-year grant totaling approximately $19.5 million from the U.S. Centers for Disease Control and Prevention, with an initial $3.9 million being awarded in the first year. Linda Niccolai, professor of epidemiology (microbial diseases) and associate dean for academic affairs, is the principal investigator.

Sangini Sheth, MD, MPH, participates in a Q&A for National Cancer Prevention Month.

New HIV medications could be on the horizon after research uncovers how HIV-1, the most common type of HIV, binds to T cells.

A new study led by Yale scientists shows that the activity of a portion of a human papillomavirus (HPV) protein does not depend on its amino acid sequence or composition.

In recognition of Cervical Cancer Awareness Month, Sangini Sheth, MD, MPH, Associate Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale Cancer Center, shares her motivation for caring for patients with cervical cancer and researching new therapies for the disease